Last Updated：2025/12/05
Recent studies show that DLBCLs respond differently to novel immunotherapies depending on their molecular subtypes.
See correct answer
Recent studies show that DLBCLs respond differently to novel immunotherapies depending on their molecular subtypes.
音声機能が動作しない場合はこちらをご確認ください
Edit Histories（0）
